Mélissa Taylor

1.8k total citations
42 papers, 954 citations indexed

About

Mélissa Taylor is a scholar working on Surgery, Genetics and Cancer Research. According to data from OpenAlex, Mélissa Taylor has authored 42 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Genetics and 10 papers in Cancer Research. Recurrent topics in Mélissa Taylor's work include Hemoglobinopathies and Related Disorders (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Mélissa Taylor is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Mélissa Taylor collaborates with scholars based in France, United States and Netherlands. Mélissa Taylor's co-authors include Françoise Farace, Gilles Vassal, Emma Pailler, Nathalie Auger, Philippe Vielh, Jochen Rößler, Birgit Geoerger, David Planchard, Benjamin Besse and Marianne Oulhen and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Mélissa Taylor

36 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélissa Taylor France 18 370 340 317 275 94 42 954
Shinji Itoyama Japan 20 478 1.3× 173 0.5× 353 1.1× 192 0.7× 66 0.7× 64 1.3k
Bálint Nagy Hungary 20 208 0.6× 120 0.4× 548 1.7× 140 0.5× 95 1.0× 52 1.1k
Yuya Kobayashi United States 9 208 0.6× 428 1.3× 552 1.7× 83 0.3× 61 0.6× 17 1.5k
Cristina Mareni Italy 19 262 0.7× 184 0.5× 374 1.2× 72 0.3× 98 1.0× 50 1.0k
John R. Gonder Canada 25 208 0.6× 328 1.0× 594 1.9× 118 0.4× 64 0.7× 64 1.9k
Francesca Diomedi‐Camassei Italy 21 147 0.4× 143 0.4× 628 2.0× 265 1.0× 293 3.1× 106 1.6k
Danuta Perek Poland 17 249 0.7× 161 0.5× 432 1.4× 251 0.9× 257 2.7× 56 1.1k
Nicoletta Orlando Italy 11 492 1.3× 183 0.5× 110 0.3× 208 0.8× 62 0.7× 26 816
Treena Cranston United Kingdom 22 442 1.2× 146 0.4× 477 1.5× 178 0.6× 40 0.4× 45 1.8k
Farideh Miraki‐Moud United Kingdom 19 295 0.8× 264 0.8× 583 1.8× 57 0.2× 123 1.3× 33 1.4k

Countries citing papers authored by Mélissa Taylor

Since Specialization
Citations

This map shows the geographic impact of Mélissa Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélissa Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélissa Taylor more than expected).

Fields of papers citing papers by Mélissa Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélissa Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélissa Taylor. The network helps show where Mélissa Taylor may publish in the future.

Co-authorship network of co-authors of Mélissa Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Mélissa Taylor. A scholar is included among the top collaborators of Mélissa Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélissa Taylor. Mélissa Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Allali, Slimane, Fabienne Marquant, Mélissa Taylor, et al.. (2023). Oral famotidine reduces the plasma level of soluble P‐selectin in children with sickle cell disease. British Journal of Haematology. 204(1). 346–351. 1 indexed citations
3.
Taylor, Mélissa, et al.. (2023). Orthopaedic Out of Bed Project (OOBP): improving early mobilisation following femoral fracture using a therapy-led education programme. BMJ Open Quality. 12(Suppl 2). e002301–e002301. 3 indexed citations
4.
Allali, Slimane, Mariane de Montalembert, Mélissa Taylor, et al.. (2022). HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease. Blood. 140(18). 1972–1982. 18 indexed citations
5.
Toubiana, Julie, Jérémie F. Cohen, Joséphine Brice, et al.. (2021). Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France. Journal of Clinical Immunology. 41(3). 526–535. 18 indexed citations
6.
Taylor, Mélissa, Tyler Wallen, J. Hunter Mehaffey, et al.. (2021). Interviews During the Pandemic: A Thoracic Education Cooperative Group and Surgery Residents Project. The Annals of Thoracic Surgery. 113(2). 663–668. 9 indexed citations
7.
Allali, Slimane, Mariane de Montalembert, Mélissa Taylor, et al.. (2020). IL-6 levels are dramatically high in the sputum from children with sickle cell disease during acute chest syndrome. Blood Advances. 4(24). 6130–6134. 7 indexed citations
8.
Taylor, Mélissa, C. Adamsbaum, Anne Devillers, et al.. (2020). Add-on bone scintigraphy after negative radiological skeletal survey for the diagnosis of skeletal injury in children suspected of physical abuse: a systematic review and meta-analysis. Archives of Disease in Childhood. 106(4). 361–366. 1 indexed citations
9.
Taylor, Mélissa, et al.. (2020). Optimizing the Duration of Trastuzumab: A Fresh Perspective. PubMed. 34(8). 296–301. 3 indexed citations
10.
Allali, Slimane, Mariane de Montalembert, Valentine Brousse, et al.. (2019). Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients. Journal of Clinical Medicine. 8(9). 1481–1481. 29 indexed citations
11.
Allali, Slimane, et al.. (2019). Transfusing children with hemoglobinopathies. Transfusion Clinique et Biologique. 26(3). 147–149.
12.
Pailler, Emma, Vincent Faugeroux, Mélissa Taylor, et al.. (2015). The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer. Expert Review of Molecular Diagnostics. 15(12). 1605–1629. 21 indexed citations
13.
Taylor, Mélissa, Fanny Billiot, Virginie Marty, et al.. (2012). Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells. Cancer Discovery. 2(5). 434–449. 37 indexed citations
14.
Massard, Christophe, Isabelle Borget, Marie‐Cécile Le Deley, et al.. (2012). Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer. European Journal of Cancer. 48(9). 1354–1362. 10 indexed citations
15.
Taylor, Mélissa, Jochen Rößler, Birgit Geoerger, Gilles Vassal, & Françoise Farace. (2010). New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future. Expert Opinion on Investigational Drugs. 19(7). 859–874. 7 indexed citations
16.
Rößler, Jochen, Mélissa Taylor, Birgit Geoerger, et al.. (2008). Angiogenesis as a target in neuroblastoma. European Journal of Cancer. 44(12). 1645–1656. 49 indexed citations
17.
Taylor, Mélissa, Catherine Dehainault, Laurence Desjardins, et al.. (2006). Genotype–phenotype correlations in hereditary familial retinoblastoma. Human Mutation. 28(3). 284–293. 62 indexed citations
18.
Taylor, Mélissa, et al.. (2005). La tumeur d'Ewing. Archives de Pédiatrie. 12(9). 1383–1391. 5 indexed citations
19.
Hogema, Boris M., Maneesh Gupta, T. Burlingame, et al.. (2001). Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nature Genetics. 29(2). 212–216. 131 indexed citations
20.
Hogema, Boris M., Mélissa Taylor, G. S. Salomons, et al.. (2001). Prenatal Diagnosis of Succinic Semialdehyde Dehydrogenase Deficiency: Increased Accuracy Employing DNA, Enzyme, and Metabolite Analyses. Molecular Genetics and Metabolism. 72(3). 218–222. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinji Itoyama Breakdown of academic impact, for papers by Bálint Nagy Breakdown of academic impact, for papers by Yuya Kobayashi Breakdown of academic impact, for papers by Cristina Mareni Breakdown of academic impact, for papers by John R. Gonder Breakdown of academic impact, for papers by Francesca Diomedi‐Camassei Breakdown of academic impact, for papers by Danuta Perek Breakdown of academic impact, for papers by Nicoletta Orlando Breakdown of academic impact, for papers by Treena Cranston Breakdown of academic impact, for papers by Farideh Miraki‐Moud
Rankless by CCL
2026